AMP-dependent kinase stimulates the expression of αKlotho

Area of Science:

• Nephrology
• Molecular Biology
• Biochemistry

Background:

• Renal αKlotho and fibroblast growth factor 23 are key regulators of phosphate and vitamin D metabolism.
• αKlotho exhibits anti-inflammatory, antioxidant, and protective effects on the kidneys and heart.
• AMP-activated protein kinase (AMPK) is an energy sensor with known nephro- and cardioprotective functions.

Purpose of the Study:

• To investigate whether AMPK regulates αKlotho gene expression in kidney cells.
• To explore the potential of AMPK as a therapeutic target for conditions involving αKlotho.

Main Methods:

• Quantitative real-time PCR and western blotting were used to measure αKlotho expression.
• Experiments involved pharmacological activation and siRNA-mediated knockdown of AMPK in kidney cell lines (Madin-Darby canine kidney, normal rat kidney 52E, and human kidney 2).
• Specific AMPK activators (AICAR, metformin, phenformin) and an inhibitor (compound C) were employed.

Main Results:

• AMPK activators significantly enhanced αKlotho gene and protein expression.
• Inhibition or knockdown of AMPK diminished the upregulation of αKlotho.
• Metformin and phenformin also demonstrated an increase in αKlotho transcripts.

Conclusions:

• AMPK acts as a potent inducer of αKlotho gene expression.
• These findings highlight a novel regulatory pathway and suggest AMPK as a potential therapeutic strategy to boost αKlotho for organ protection.